REG - Primary Health Props - Results of AGM voting

Primary Health PropertiesAnnouncement

Today 13:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260429:nRSc4415Ca&default-theme=true

RNS Number : 4415C  Primary Health Properties PLC  29 April 2026

29 April 2026

Primary Health Properties PLC

 

Results of AGM voting

 

Primary Health Properties PLC (the "Company" or "PHP") announces that at the
Annual General Meeting of the Company held today 29 April 2026, all of the
resolutions, as set out in full in the Notice of Meeting, were duly passed on
a poll by the requisite majority. Any proxy votes which were at the discretion
of the Chair have been included in the "For" total.

For information the votes cast were as follows:

 Resolution                                                                   For (including discretionary)          Against             Votes Total    % of ISC Voted  Withheld(1)
                                                                                             Votes                   %            Votes  %
 1. To receive the Annual Report and Accounts for the year ended 31 December  1,641,121,456  99.97                   414,633      0.03   1,641,536,089  63.25%          13,808,004
 2025

 2. To approve the Directors' remuneration report                             1,600,369,057  96.75                   53,677,283   3.25   1,654,046,340  63.74%          1,297,753

 3. To approve the Company's dividend policy                                  1,654,337,973  99.97                   474,258      0.03   1,654,812,231  63.77%          531,862

 4. To authorise a scrip dividend                                             1,652,654,869  99.88                   1,976,918    0.12   1,654,631,787  63.76%          712,306

 5. To approve the re-appointment of Deloitte LLP as auditor                  1,552,494,333  93.90                   100,925,107  6.10   1,653,419,440  63.71%          1,924,653

 6. To authorise the Audit Committee to fix the auditor's remuneration        1,637,186,339  99.02                   16,240,701   0.98   1,653,427,040  63.71%          1,917,053

 7. To re-elect Harry Hyman as a Director                                     1,475,299,216  89.22                   178,293,697  10.78  1,653,592,913  63.72%          1,751,180

 8. To re-elect Mark Davies as a Director                                     1,648,200,859  99.63                   6,114,301    0.37   1,654,315,160  63.75%          1,028,933

 9. To re-elect Richard Howell as a Director                                  1,648,078,879  99.62                   6,240,256    0.38   1,654,319,135  63.75%          1,024,958

 10. To re-elect Ian Krieger as a Director                                    1,622,703,426  98.09                   31,605,943   1.91   1,654,309,369  63.75%          1,034,724

 11. To re-elect Ivonne Cantú as a Director                                   1,544,184,456  93.34                   110,113,205  6.66   1,654,297,661  63.75%          1,046,432

 12. To elect Jonathan Davies as a Director                                   1,653,139,239  99.93                   1,165,720    0.07   1,654,304,959  63.75%          1,039,134

 13. To re-elect Laure Duhot as a Director                                    1,623,310,804  98.86                   18,737,792   1.14   1,642,048,596  63.27%          13,295,497

 14. To re-elect Dr Bandhana Rawal as a Director                              1,635,565,662  98.87                   18,717,208   1.13   1,654,282,870  63.75%          1,061,223

 15. To authorise the making of political donations                           1,574,889,087  95.55                   73,350,687   4.45   1,648,239,774  63.51%          7,098,319

 16. To approve Directors' fees under the Articles                            1,643,074,801  99.40                   9,934,462    0.60   1,653,009,263  63.70%          2,334,830

 17. To authorise the Directors  to allot shares                              1,560,331,740  94.31                   94,136,870   5.69   1,654,468,610  63.75%          875,483

 18. To authorise the Directors to disapply pre-emption rights *              1,590,241,533  96.13                   63,968,617   3.87   1,654,210,150  63.74%          1,133,943

 19. To disapply pre-emption rights in connection with an acquisition or      1,520,143,930  91.90                   134,036,230  8.10   1,654,180,160  63.74%          1,163,933
 specified capital investment*
 20. To hold general meetings on 14 days' notice*                             1,561,992,106  94.40                   92,651,641   5.60   1,654,643,747  63.76%          700,346

 21. To purchase own shares*                                                  1,648,291,629  99.66                   5,608,765    0.34   1,653,900,394  63.73%          1,443,699

 

 

(1)A vote withheld is not a vote in law and is not counted in the calculation
of the proportion of votes for or against a resolution

 

* indicates a special resolution

 

A copy of the resolutions passed as special business at today's AGM will be
submitted to the National Storage Mechanism and will be available at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

For further information contact:

Mark Davies CEO
 
Richard Howell CFO

Primary Health Properties PLC
     Primary Health Properties PLC

 

David Purcell Investor Relations

Primary Health Properties PLC

T: +44 (0) 7921 190 136

E: david.purcell@phpgroup.co.uk

 

Sodali & Co Financial PR

Elly Williamson/Louisa Henry/Saskia Bottomley

T: +44 (0) 207 250 1446 E: PHP@client.sodali.com

 

 The Company has a primary listing on the London Stock Exchange and a
secondary listing on the JSE Limited.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGUKAURNBUSUAR



            Copyright 2019 Regulatory News Service, all rights reserved